Cargando…
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer’s disease (AD), increasing risk and decreasing age of disease onset. Many studies have demonstrated the detrimental effects of apoE4 in varying cellular contexts. However, the underlying mechanisms explaining how apoE4 leads to c...
Autores principales: | Najm, Ramsey, Jones, Emily A., Huang, Yadong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558779/ https://www.ncbi.nlm.nih.gov/pubmed/31186040 http://dx.doi.org/10.1186/s13024-019-0324-6 |
Ejemplares similares
-
Apolipoprotein E and Alzheimer's disease
por: Troutwine, Benjamin R., et al.
Publicado: (2022) -
Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease
por: Leduc, Valérie, et al.
Publicado: (2011) -
Apolipoprotein E ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
por: Kotze, MJ, et al.
Publicado: (2015) -
Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective
por: Suidan, Georgette L., et al.
Publicado: (2019) -
Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2020)